- E34.321 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
- The 2024 edition of ICD-10-CM E34.321 became effective on October 1, 2022.
- This is the American ICD-10-CM version of E34.321 – other international versions of ICD-10 E34.321 may differ.
ICD-10-CM E34.321 is grouped within Diagnostic Related Group(s):
- 643 Endocrine disorders with mcc
- 644 Endocrine disorders with cc
- 645 Endocrine disorders without cc/mcc
Applicable To
- Acid-labile subunit gene (IGFALS) defect
- Growth hormone gene 1 (GH1) defect with growth hormone neutralizing antibodies
- Growth hormone insensitivity syndrome (GHIS)
- Insulin-like growth factor 1 gene (IGF1) defect
- Laron type short stature
- Severe primary insulin-like growth factor-1 deficiency (SPIGFD)
- Signal transducer and activator of transcription 5B gene (STAT5b) defect
Code History
- 2024 (effective 10/1/2022): New code
- 2024 (effective 10/1/2022): No change
Diagnosis Index entries containing back-references to E34.321:
- Laron-type > Dwarfism E34.328
- acid-labile subunit gene defect (IGFALS) > genetic causes E34.329
- growth hormone gene 1 defect with growth hormone neutralizing antibodies (GH1) > genetic causes E34.329
- growth hormone insensitivity syndrome (GHIS) > genetic causes E34.329
- insulin-like growth factor 1 gene defect (IGF1) > genetic causes E34.329
- primary insulin-like growth factor-1 deficiency (IGF-1) > genetic causes E34.329
- severe primary insulin-like growth factor-1 deficiency (SPIGFD) > genetic causes E34.329
- signal transducer and activator of transcription 5B gene defect (STAT5b) > genetic causes E34.329
- Laron-type > stature NEC (child) (hereditary) (idiopathic) R62.52